AH Related Analyst EPS View
-
Dougherty & Co Starts Accretive Health (AH) at Buy
-
Oppenheimer Reiterates an 'Outperform' on Accretive Health (AH); Settling Up with Minnesota AG
-
UPDATE - UBS Downgraded Accretive Health (AH) to Neutral; Possibility Of More Issues Lurking
Back to AH Stock Lookup
